CASPR Is Hiring

Key Takeaways

• CASPR adds three senior leadership positions
• Roles focus on research, policy, and advocacy
• Director of Research will drive clinical trial partnerships
• Policy team targets NIH funding and gambling legislation
• Open applications posted on Idealist and Google Docs

Summary

CASPR announced three senior hires: Director of Research, Director of Policy, and Policy Lead. The research director will lead scientific collaborations, identify clinical trial opportunities, and ensure evidence‑based policy. The policy roles will advance legislative initiatives, including NIH trial funding and online gambling addiction measures. Applications are available via Idealist and Google Docs.

Pulse Analysis

The addiction research landscape is at a pivotal juncture, with mounting evidence linking substance use disorders to broader societal costs. Organizations like CASPR, which blend scientific rigor with policy advocacy, are uniquely positioned to translate findings into actionable programs. By recruiting a Director of Research, CASPR aims to deepen partnerships with academic institutions, secure trial sites, and embed robust data into its policy recommendations, thereby strengthening the credibility of its proposals.

Leadership in policy is equally critical as federal agencies grapple with funding allocations and emerging behavioral health challenges. The newly created Director of Policy and Policy Lead will spearhead efforts on Capitol Hill, targeting increased NIH support for addiction trials and crafting legislation to curb online gambling addiction. Their work will bridge the gap between researchers and lawmakers, ensuring that evidence‑based solutions receive the legislative backing needed for large‑scale implementation.

Beyond CASPR’s internal growth, these hires reflect a broader trend of nonprofit organizations scaling expertise to influence health policy. As talent pools tighten, the visibility of open roles on platforms like Idealist signals a competitive market for seasoned professionals. Stakeholders—from investors to advocacy groups—should monitor how CASPR’s expanded team accelerates policy change, potentially reshaping funding streams and regulatory frameworks across the addiction treatment sector.